| 1 | 
                
                    Cidofovir
                
             | 1件:  Cidofovir Cidofovir | 1件:  D00273 
                
                    D00273
                
             | - | - | 1件:  25 25 | 
| 2 | 
                
                    Cytarabine
                
             | 1件:  Cytarabine Cytarabine | 3件:  D00168 
                
                    D00168
                
            , 
                
                    D03046
                
            , 
                
                    D03637
                
             | - | - | 7件:  11 11, 13, 14, 25, 49, 60, 65 | 
| 3 | 
                
                    Didanosine
                
             | 1件:  Didanosine Didanosine | 1件:  D00296 
                
                    D00296
                
             | - | - | 2件:  25 25, 265 | 
| 4 | 
                
                    Efineptakin alfa
                
             | 1件:  NT-I7 NT-I7 | 1件:  D11957 
                
                    D11957
                
             | - | - | 1件:  25 25 | 
| 5 | 
                
                    Emtricitabine
                
             | 2件:  Emtricitabine Emtricitabine; TRUVADA | 1件:  D01199 
                
                    D01199
                
             | - | - | 4件:  25 25, 93, 265, 325 | 
| 6 | 
                
                    Enfuvirtide
                
             | 1件:  Enfuvirtide Enfuvirtide | 1件:  D02499 
                
                    D02499
                
             | - | - | 2件:  25 25, 265 | 
| 7 | 
                
                    Filgrastim
                
             | 7件:  FILGRASTIM FILGRASTIM; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio | 1件:  D03235 
                
                    D03235
                
             | 1件:  CSF3R CSF3R 💬 | 5件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 34件:  2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 | 
| 8 | 
                
                    Interferon alfa
                
             | 1件:  Interferon alfa Interferon alfa | 1件:  D03305 
                
                    D03305
                
             | 2件:  IFNAR1 IFNAR1, IFNAR2 💬 | 18件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 6件:  13 13, 25, 26, 28, 56, 96 | 
| 9 | 
                
                    Interferon alfa-2b
                
             | 2件:  Interferon alfa-2b Interferon alfa-2b; Interferon alpha-2B | 1件:  D02745 
                
                    D02745
                
             | 2件:  IFNAR1 IFNAR1, IFNAR2 💬 | 18件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件:  25 25, 34 | 
| 10 | 
                
                    Interleukin-7
                
             | 2件:  Interleukin-7 Interleukin-7; Recombinant human interleukin-7 | - | - | - | 1件:  25 25 | 
| 11 | 
                
                    Mefloquine
                
             | 2件:  Lariam Lariam; Mefloquine | 1件:  D04895 
                
                    D04895
                
             | - | - | 2件:  25 25, 46 | 
| 12 | 
                
                    Methylprednisolone
                
             | 4件:  Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | 6件:  D00407 
                
                    D00407
                
            , 
                
                    D00751
                
            , 
                
                    D00979
                
            , 
                
                    D05000
                
            , 
                
                    D05001
                
            , 
                
                    D05002
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 | 
| 13 | 
                
                    Natalizumab
                
             | 2件:  Natalizumab Natalizumab; TYSABRI | 1件:  D06886 
                
                    D06886
                
             | 1件:  ITGA4 ITGA4 💬 | 14件:  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 6件:  13 13, 15, 25, 46, 63, 96 | 
| 14 | 
                
                    Pembrolizumab
                
             | 1件:  Pembrolizumab Pembrolizumab | 1件:  D10574 
                
                    D10574
                
             | 1件:  PDCD1 PDCD1 💬 | 3件:  Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件:  25 25, 285 | 
| 15 | 
                
                    Prednisolone
                
             | 3件:  Prednisolona Prednisolona; Prednisolone; Prednisolonum | 8件:  D00472 
                
                    D00472
                
            , 
                
                    D00980
                
            , 
                
                    D00981
                
            , 
                
                    D00982
                
            , 
                
                    D01239
                
            , 
                
                    D01998
                
            , 
                
                    D02156
                
            , 
                
                    D03301
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件:  3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 | 
| 16 | 
                
                    Probenecid
                
             | 1件:  Probenecid Probenecid | 1件:  D00475 
                
                    D00475
                
             | - | - | 1件:  25 25 | 
| 17 | 
                
                    Tenofovir
                
             | 1件:  Tenofovir Tenofovir | 1件:  D06074 
                
                    D06074
                
             | - | - | 6件:  2 2, 13, 25, 93, 265, 325 | 
| 18 | 
                
                    Teriflunomide
                
             | 2件:  AUBAGIO AUBAGIO; Teriflunomide | 1件:  D10172 
                
                    D10172
                
             | 1件:  DHODH DHODH 💬 | 3件:  Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 3件:  13 13, 25, 26 | 
| 19 | 
                
                    Topotecan
                
             | 1件:  Topotecan Topotecan | 2件:  D02168 
                
                    D02168
                
            , 
                
                    D08618
                
             | 1件:  TOP1 TOP1 💬 | - | 1件:  25 25 | 
| 20 | 
                
                    Zalcitabine
                
             | 1件:  Zalcitabine Zalcitabine | 1件:  D00412 
                
                    D00412
                
             | - | - | 1件:  25 25 | 
| 21 | 
                
                    Zidovudine
                
             | 3件:  COMBIVIR COMBIVIR; Retrovir; Zidovudine | 1件:  D00413 
                
                    D00413
                
             | - | - | 7件:  25 25, 26, 94, 135, 265, 325, 331 |